Adrenaloma

JayaSakthi5 119 views 45 slides Jun 09, 2021
Slide 1
Slide 1 of 45
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45

About This Presentation

adrenal incidentaloma


Slide Content

Adrenal Incidentaloma Dr.Jaya Sakthi Post-Graduate 2nd year Department of General Surgery 06/04/2019

OUTLINE Surgical anatomy Relevant physiology Incidentaloma definition and classification Evaluation Functioning tumors Management Surgical indications Surgical options

SURGICAL ANATOMY

Relevant physiology

3 metabolites Metanephrine Nor metanephrine VMA 2 enzymes COMT MOA

Adrenal Incidentaloma Incidentally discovered adrenal masses, also termed clinically inapparent adrenal masses or incidentalomas, are discovered through imaging performed for unrelated nonadrenal disease. Found in 4-6% on CT scans Functioning or nonfunctioning

EVALUATION Evaluation begins with history taking, with a focus on prior malignant disease, hypertension, and symptoms of glucocorticoid or sex steroid excess. Laboratory investigations to evaluate abnormalities in physiological functions. Imaging studies.

Laboratory investigations To evaluate abnormalities in HPA Axis: Baseline morning plasma cortisol 24 hrs urinary free cortisol Midnight salivary or free cortisol Morning plasma cortisol after overnight 1mg dexamethasone suppression Others: Serum testosterone DHEA Sulphate Androstenodione 11 deoxycortisol

PLASMA OR URINARY METANEPHRINES

IMAGING Characteristics suggestive of a benign lesion on CT scan include homogeneous appearance, well-defined borders, high lipid content, rapid washout of contrast material, and low degree of vascularity. Features that are concerning for malignancy include irregular or ill-defined borders, necrosis, internal calcifications or hemorrhage, and high vascularity

Adrenocortical adenoma: * <4cm * Lipid rich(<10 HU) * homogenous with smooth borders * 30% Lipid poor  10-30 HU  Contrast washout >60% in 15 minutes Malignancy: * Heterogenous lesions with irregular margins * Calcifications Suspicion of malignancy: <2% for lesions < 4cm 2%-6% for lesions 4-6cm 25% for lesions >6cm

Other imaging studies: I 123 MIBG Scintigraphy FDG PET 6-FDOPA PET Somatostatin receptor based scans

FUNCTIONAL ADRENAL TUMORS CUSHING SYNDROME HYPER CORTISOLISM CONNS SYNDROME PRIMARY ALDOSTERONISM PHEOCHROMOCYTOMA TUMOR OF ADRENAL MEDULLA ADRENAOCORTICAL CARCINOMA HIGHLY AGGRESSIVE TUMOR

Cushing’s Syndrome Symptoms : weight gain, central obesity, rounded facies , dorsocervical (back of the neck) fat pad, easy bruising, thin skin, poor wound healing, purple abdominal striae , acne, hirsutism , infertility, depression, irritability, opportunistic infections Signs : hypertension, diabetes, impaired glucose tolerance, osteoporosis, osteopenia, hypokalemia, leukocytosis with relative lymphopenia ,

Cushing’s Syndrome Screening tests *24 hour urine cortisol Values higher than 3-4 times normal are highly suggestive of autonomous cortisol secretion. *Overnight 1-mg dexamethasone suppression test Patient takes 1 mg dex pill at 11 PM, then fasts, then presents to lab at 8:00 AM for measurement of serum cortisol . Serum cortisol level > 5 mcg/dl is highly suggestive of autonomous cortisol secretion.

Primary hyperaldosteronism Symptoms : Nocturia, polyuria, muscle cramps, palpitations Signs : Hypertension, hypernatremia, hypokalemia

Primary Aldosteronism Plasma renin activity (PRA) and plasma aldosterone concentration Aldo/PRA ratio of  20 with aldo level of  15 ng /dl is positive result

Pheochromocytoma Symptoms : (in paroxysms) tachycardia, palpitations, pallor, tremor, headache, diaphoresis. May be precipitated by maneuvers that increase intra-abdominal pressure (Valsalva, lifting, pregnancy, postural), or by anxiety, or by medicines such as reglan. Signs : Hypertension, orthostatic hypotension, pallor, retinopathy, fever, tremor ,tachycardia, diaphoresis, headache, cardiac arrhythmias, left ventricular dysfunction.

Pheochromocytoma Catecholamines : epinephrine, norepinephrine , dopamine Metanephrines : metanephrine , normetanephrine

Pheochromocytoma Recommendation 24 hr urine fractionated catecholamines and 24 hr urine fractionated metanephrines . Plasma free metanephrines

Adrenocortical Carcinoma Symptoms/Signs : “Salt” – Aldosteronsim “Sugar” – Cushing’s syndrome “Sex” androgens : hirsutism , acne, oily skin, amenorrhea, oligomenorrhea , increased libido estrogens : gynecomastia , testicular atrophy

MANAGEMENT Surgery is the treatment of choice for endocrine active or likely malignant and resectable ACTs and for all PCs and PGLs. A course of cortisol-lowering agents such as ketoconazole or metyrapone may be considered before surgery. A course of cortisol-lowering agents such as ketoconazole or metyrapone may be considered before surgery.

The preoperative management of PC and PGL resection includes α-blockade and volume repletion. Finally, the risk of hemodynamic instability after surgical removal of PC or PGL requires close monitoring in the postoperative period in an intensive care unit

ADRERNALECTOMY Open adrenalectomy can be broadly classified into transperitoneal and retroperitoneal approaches. Transperitoneal approaches include the anterior transabdominal and thoracoabdominal approaches, where the main advantages lie in excellent surgical exposure and better access to the hilum and great vessels. Disadvantage: intra abdominal organ injury.

Retroperitoneal approaches include the flank and posterior lumbodorsal approaches, which result in a smaller operative field but are associated with less ileus and shorter hospitalization. In addition, the retroperitoneal approach is ideal for the morbidly obese patient.

THANK YOU